Jalyn (dutasteride and tamsulosin HCL) capsules
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – June 2012
WARNINGS and PRECAUTIONS
Evaluation for Other Urological Diseases
- Prior to initiating treatment with Jalyn, consideration should be given to other urological conditions that may cause similar symptoms. In addition, BPH and prostate cancer may coexist.